Wahed Invest’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,875
Closed -$164K 227
2024
Q2
$164K Buy
3,875
+416
+12% +$22.9K 0.03% 217
2024
Q1
$239K Buy
3,459
+412
+14% +$26.1K 0.05% 196
2023
Q4
$225K Buy
3,047
+227
+8% +$14.9K 0.06% 184
2023
Q3
$192K Buy
2,820
+272
+11% +$23.1K 0.06% 192
2023
Q2
$239K Buy
2,548
+224
+10% +$17.5K 0.08% 165
2023
Q1
$158K Buy
2,324
+492
+27% +$31.6K 0.07% 191
2022
Q4
$90.7K Sell
1,832
-212
-10% -$8.66K 0.05% 215
2022
Q3
$66K Buy
2,044
+176
+9% +$7.26K 0.04% 222
2022
Q2
$74K Buy
+1,868
New +$99.9K 0.05% 221
2022
Q1
Sell
-2,168
Closed -$169K 185
2021
Q4
$169K Buy
+2,168
New +$191K 0.09% 179

Other funds holding EXAS

Wahed Invest's EXAS Position: Q3 2024 in Review

Wahed Invest sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 3,875 shares — an estimated $164K sold.

Wahed Invest first reported a position in EXAS in Q4 2021 and held it in 10 quarters. The position peaked at $239K in Q2 2023. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Wahed Invest reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Wahed Invest sold 3,875 Exact Sciences shares in Q3 2024, an estimated $164K.
  • Wahed Invest first reported a position in Exact Sciences in Q4 2021 and held it in 10 quarters.
  • Wahed Invest's Exact Sciences position peaked at $239K in Q2 2023.
  • 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Wahed Invest's 13F filing for Q3 2024, filed 14 Nov 2024.